MedTrace Logo

MINIject Global Long-Term Follow-up Study

NCT04524416 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-02-28

No results posted yet for this study

Summary

The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.

Conditions

Interventions

DEVICE

Minimally invasive glaucoma surgery (MIGS)

MINIject implant placed into supraciliary space. The implantation was done in a previous study in which patient participated and is not part of this study.

Sponsors & Collaborators

  • iSTAR Medical

    lead INDUSTRY

Principal Investigators

  • Zubair Hussain, PhD · iSTAR Medical

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-05
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Colombia
  • France
  • Germany
  • India
  • Panama
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04524416 on ClinicalTrials.gov